164 related articles for article (PubMed ID: 25004968)
1. Structural insights into interactions of C/EBP transcriptional activators with the Taz2 domain of p300.
Bhaumik P; Davis J; Tropea JE; Cherry S; Johnson PF; Miller M
Acta Crystallogr D Biol Crystallogr; 2014 Jul; 70(Pt 7):1914-21. PubMed ID: 25004968
[TBL] [Abstract][Full Text] [Related]
2. Structural insights into TAZ2 domain-mediated CBP/p300 recruitment by transactivation domain 1 of the lymphopoietic transcription factor E2A.
Lochhead MR; Brown AD; Kirlin AC; Chitayat S; Munro K; Findlay JE; Baillie GS; LeBrun DP; Langelaan DN; Smith SP
J Biol Chem; 2020 Mar; 295(13):4303-4315. PubMed ID: 32098872
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation.
Feng H; Jenkins LM; Durell SR; Hayashi R; Mazur SJ; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Bai Y
Structure; 2009 Feb; 17(2):202-10. PubMed ID: 19217391
[TBL] [Abstract][Full Text] [Related]
4. Insulin suppresses transactivation by CAAT/enhancer-binding proteins beta (C/EBPbeta). Signaling to p300/CREB-binding protein by protein kinase B disrupts interaction with the major activation domain of C/EBPbeta.
Guo S; Cichy SB; He X; Yang Q; Ragland M; Ghosh AK; Johnson PF; Unterman TG
J Biol Chem; 2001 Mar; 276(11):8516-23. PubMed ID: 11116148
[TBL] [Abstract][Full Text] [Related]
5. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.
Jenkins LM; Yamaguchi H; Hayashi R; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Mazur SJ
Biochemistry; 2009 Feb; 48(6):1244-55. PubMed ID: 19166313
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the transactivation domain of B-Myb with the TAZ2 domain of the coactivator p300: molecular features and properties of the complex.
Oka O; Waters LC; Strong SL; Dosanjh NS; Veverka V; Muskett FW; Renshaw PS; Klempnauer KH; Carr MD
PLoS One; 2012; 7(12):e52906. PubMed ID: 23300815
[TBL] [Abstract][Full Text] [Related]
7. Structure of the Taz2 domain of p300: insights into ligand binding.
Miller M; Dauter Z; Cherry S; Tropea JE; Wlodawer A
Acta Crystallogr D Biol Crystallogr; 2009 Dec; 65(Pt 12):1301-8. PubMed ID: 19966416
[TBL] [Abstract][Full Text] [Related]
8. Structures of KIX domain of CBP in complex with two FOXO3a transactivation domains reveal promiscuity and plasticity in coactivator recruitment.
Wang F; Marshall CB; Yamamoto K; Li GY; Gasmi-Seabrook GM; Okada H; Mak TW; Ikura M
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6078-83. PubMed ID: 22474372
[TBL] [Abstract][Full Text] [Related]
9. Structure of p300 bound to MEF2 on DNA reveals a mechanism of enhanceosome assembly.
He J; Ye J; Cai Y; Riquelme C; Liu JO; Liu X; Han A; Chen L
Nucleic Acids Res; 2011 May; 39(10):4464-74. PubMed ID: 21278418
[TBL] [Abstract][Full Text] [Related]
10. Interaction and cooperation of the CCAAT-box enhancer-binding protein β (C/EBPβ) with the homeodomain-interacting protein kinase 2 (Hipk2).
Steinmann S; Coulibaly A; Ohnheiser J; Jakobs A; Klempnauer KH
J Biol Chem; 2013 Aug; 288(31):22257-69. PubMed ID: 23782693
[TBL] [Abstract][Full Text] [Related]
11. CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding.
De Guzman RN; Wojciak JM; Martinez-Yamout MA; Dyson HJ; Wright PE
Biochemistry; 2005 Jan; 44(2):490-7. PubMed ID: 15641773
[TBL] [Abstract][Full Text] [Related]
12. CCAAT/Enhancer-binding protein beta DNA binding is auto-inhibited by multiple elements that also mediate association with p300/CREB-binding protein (CBP).
Lee S; Miller M; Shuman JD; Johnson PF
J Biol Chem; 2010 Jul; 285(28):21399-410. PubMed ID: 20452968
[TBL] [Abstract][Full Text] [Related]
13. CCAAT/enhancer-binding protein family members recruit the coactivator CREB-binding protein and trigger its phosphorylation.
Kovács KA; Steinmann M; Magistretti PJ; Halfon O; Cardinaux JR
J Biol Chem; 2003 Sep; 278(38):36959-65. PubMed ID: 12857754
[TBL] [Abstract][Full Text] [Related]
14. The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression.
Coulibaly A; Haas A; Steinmann S; Jakobs A; Schmidt TJ; Klempnauer KH
PLoS One; 2018; 13(2):e0190934. PubMed ID: 29394256
[TBL] [Abstract][Full Text] [Related]
15. The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.
Jansma AL; Martinez-Yamout MA; Liao R; Sun P; Dyson HJ; Wright PE
J Mol Biol; 2014 Dec; 426(24):4030-4048. PubMed ID: 25451029
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein.
Ferreon JC; Martinez-Yamout MA; Dyson HJ; Wright PE
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13260-5. PubMed ID: 19651603
[TBL] [Abstract][Full Text] [Related]
17. Interaction and functional collaboration of p300 and C/EBPbeta.
Mink S; Haenig B; Klempnauer KH
Mol Cell Biol; 1997 Nov; 17(11):6609-17. PubMed ID: 9343424
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of CBP/p300 recruitment by the microphthalmia-associated transcription factor.
Brown AD; Vergunst KL; Branch M; Blair CM; Dupré DJ; Baillie GS; Langelaan DN
Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119520. PubMed ID: 37353163
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for recruitment of CBP/p300 coactivators by STAT1 and STAT2 transactivation domains.
Wojciak JM; Martinez-Yamout MA; Dyson HJ; Wright PE
EMBO J; 2009 Apr; 28(7):948-58. PubMed ID: 19214187
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the p300 Taz2-p53 TAD2 complex and comparison with the p300 Taz2-p53 TAD1 complex.
Miller Jenkins LM; Feng H; Durell SR; Tagad HD; Mazur SJ; Tropea JE; Bai Y; Appella E
Biochemistry; 2015 Mar; 54(11):2001-10. PubMed ID: 25753752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
